TLRY$7.51
$7.5299
Chart
Performance
Key Stats
AI TLRY Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
NeutralTilray Brands shows mixed signals. While there are positive thematic elements in the cannabis sector, fundamental performance and technical indicators present challenges, suggesting a neutral outlook for investors.
Thematic
Tilray Brands operates in the evolving cannabis industry, benefiting from increasing legalization trends but also facing regulatory uncertainties and intense competition.
Fundamental
Tilray Brands faces significant financial challenges, characterized by consistent net losses, negative free cash flow, and a high debt load, although revenue shows some growth.
Technical
The stock exhibits a moderately bullish technical profile, with recent price action above key moving averages and some positive momentum indicators, but it remains below its 52-week high.
| Factor | Score |
|---|---|
| Cannabis Legalization & Market Growth | 75 |
| Regulatory Landscape | 40 |
| Diversification (Beverage Alcohol, Wellness) | 60 |
| Competition | 50 |
| Brand Portfolio | 70 |
| Factor | Score |
|---|---|
| Valuation | 40 |
| Profitability | 15 |
| Growth | 35 |
| Balance Sheet Health | 45 |
| Cash Flow | 40 |
| Factor | Score |
|---|---|
| Trend Analysis | 55 |
| Momentum | 60 |
| Volume Confirmation | 70 |
| Support & Resistance | 50 |
| Moving Average Convergence Divergence (MACD) | 65 |
AI Investing Checklist
Powered by LiveAIBullish Points (7)
Improving Cash Position
Cash equivalents have increased from $206.63 million in Q2 2023 to $228.34 million in Q2 2024, indicating improved liquidity.
Strong Debt Coverage by Cash
The company's cash equivalents ($228.34M) are a significant portion of its total debt ($387.32M), suggesting a reasonable ability to manage its debt obligations with current liquid assets.
Bearish Points (11)
Consistent Net Losses
The company has consistently reported net losses in all reported periods, with a significant net loss of -$244.98M in Q2 2024.
High Price-to-Sales Ratio
The trailing Price-to-Sales (P/S) ratio of 1.1 is high given the consistent net losses, suggesting a high valuation relative to current revenue.
Calendar
July 2025
29
Next Earnings Date
H: $0.01
A: $0.01
L: $0.01
H: 282.00M
A: 250.41M
L: 232.20M
Profile
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Seasonals
Price Target
1.32 USD
The 39 analysts offering 1 year price forecasts for TLRY have a max estimate of 2.50 and a min estimate of 0.60.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 95
Canopy Growth is a direct and major competitor to Tilray in the Canadian and international cannabis markets, both vying for market share in medical and recreational segments.
Weight: 93
Aurora Cannabis is another leading Canadian licensed producer, making it a primary direct competitor to Tilray across various cannabis product categories and international expansion efforts.
Weight: 90
SNDL is a prominent Canadian cannabis company with a diverse portfolio, including cannabis cultivation, retail, and liquor store operations, directly competing with Tilray in multiple verticals.
Weight: 88
Cronos Group is a Canadian licensed producer backed by Altria, making it a significant competitor to Tilray in the evolving cannabis industry, particularly in product development and market reach.